Nebraska’s AG is lone holdout in pursuing opioid cases
LINCOLN, Neb. (AP) — Nebraska Attorney General Doug Peterson has fought prescription opioid abuse through public education campaigns, worked with lawmakers to tighten prescribing practices and even demanded documents from the maker of OxyContin. He has said the overdose crisis is ravaging families.
What Peterson hasn’t done is pursued a lawsuit seeking to hold any opioid manufacturer, distributor or pharmaceutical company accountable. That leaves him standing alone among state attorneys general.
Every other state has sued, filed administrative charges or promised to sue the companies blamed for the national crisis, which played a role in the deaths of more than 390,000 Americans from 2000 through 2017. Peterson’s decision to stand on the sidelines, at least so far, has frustrated some who want to make sure that Nebraska is in line to receive its fair share of money under any national settlement.
“We as a state have been great and our attorney general has been wonderful in recognizing the opioid problem,” said state Sen. Sara Howard, of Omaha, whose sister died of an overdose in 2009. “It’s really baffling to me why we haven’t joined (the lawsuits).”
Howard sent a letter to Peterson last month urging him to join a group of some 1,500 opioid-related lawsuits from around the country that are consolidated under a federal judge in Ohio, but said she received no response. She said Nebraska has more work to do and that she would like to see the drug companies pay for treatment and prevention programs.
In a statement, Peterson spokeswoman Suzanne Gage said state lawyers talk regularly with private attorneys and other states that have filed opioid-related lawsuits. Gage would not rule out future legal action, but declined to say why the state has not yet proceeded with a claim of its own.
After a flurry of legal filings in recent weeks, 48 states have sued to recover damages they say are caused by the opioid crisis, while Michigan’s attorney general has announced her intention to sue and has solicited bids from outside law firms to handle the case.
Nebraska stands out for another reason. Its opioid-related death rate in 2017 was the lowest of all states, with advocates saying addictions to alcohol and methamphetamine are more pervasive. Even so, tribal and local government officials say opioid abuse has led to a rise in law enforcement and public health costs.
That’s among the reasons that led several of them to file their own lawsuits.
The Ponca Tribe last year sued Purdue Pharma, the Connecticut-based maker of OxyContin, and other pharmaceutical companies. The state’s other three tribes quickly joined.
“We have a responsibility to make sure we’re protecting the health of our citizens and being proactive wherever we can,” said Larry Wright Jr., the Ponca tribe’s chairman.
Five Nebraska counties — three rural and two in the Omaha area — also filed lawsuits, as did South Sioux City. Douglas County, which includes Omaha, claimed in its January lawsuit that the epidemic has saddled officials “with an enormous economic burden” and led to more crime and children in foster care.
Nationally, more than 2,000 state, local and tribal governments have sued Purdue.
Several Nebraska lawyers involved in the local opioid cases said they were surprised the attorney general’s office hasn’t yet filed a lawsuit to help the state recover the costs of health care, law enforcement and social services.
“From a lawyer’s standpoint, it seems to me you’d be in a better position if you have a lawsuit on file and are engaged in the litigation process,” said Ed Hotz, one of the attorneys representing Douglas County. “But maybe the attorney general has his reasons. I’m just not sure what they are.”
The go-slow approach is in keeping with how Peterson, a Republican, handles his job. Now in his second term, the former assistant attorney general and deputy county counsel has always billed himself as a “workhorse, not a show horse.”
While he has accepted campaign donations from pharmaceutical companies, including industry giants Pfizer and Eli Lilly, state campaign finance records show Peterson has received no money from Purdue Pharma or other major defendants in the opioid lawsuits.
Even without suing, Peterson has taken an active role in trying to address the problems caused by opioid addiction.
Last year, he worked with state lawmakers on new monitoring requirements for prescription drugs and restrictions on how much doctors could prescribe at one time. In 2017, he joined a coalition of 41 attorneys general that issued subpoenas to drugmakers and demanded Purdue turn over documents. His office helped launch a public awareness campaign that included television and internet ads.
“We are joining forces to work together in protecting Nebraskans from the harmful impacts of addiction and the ravages it can cause to families and futures,” Peterson said at the time. “Nebraskans are not immune from this problem. We all need to work together and do something about it.”
Peterson also played a major role on the Nebraska Coalition to Prevent Opioid Abuse, a working group that emphasized public awareness, increased training for health care providers and expanded use of naloxone, a potentially life-saving drug for opioid users who have overdosed.
But he also has tried to deter local governments from taking matters into their own hands. In an April 2018 letter to Nebraska’s associations for cities and counties, Peterson said it was unnecessary for local governments to file their own lawsuits because the state would likely distribute settlement money to them if it received a share.
He did not elaborate on how Nebraska would collect the money, and Peterson’s spokeswoman declined to comment further. In the letter, Peterson said his office was “actively engaged” in talks over how to hold opioid makers accountable and was still investigating the matter with other states.
It’s not clear whether a government entity that does not sue could miss out on a nationwide settlement with the opioid industry or individual companies. States are being represented in the federal settlement talks in Ohio, regardless of whether they filed claims, but it’s not certain that there eventually will be a settlement. How that money would be distributed also would be subject to negotiations.
Paul Hanly, whose firm represents about 250 local governments in opioid litigation, said many governments that initially were reluctant to sue now realize there is no downside to taking action. The number of court filings from states has surged since last year, and in March Purdue reached a $270 million settlement with Oklahoma.
“I think the Oklahoma settlement has got attorneys general saying, ‘I’d better get on board here,’” he said.
Mulvihill reported from Cherry Hill, New Jersey.